Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 933 blog entries.

August 2025

Deep Bio and Techcyte Collaborate to Bring AI Prostate and Frozen Section Solutions to Fusion® Platform

2025-09-16T10:23:17+00:00

Deep Bio and Techcyte expand digital pathology with AI-powered prostate and frozen section solutions on the Fusion® platform. Deep Bio, a global leader in AI-powered cancer diagnostics, today announced a strategic partnership with Techcyte to integrate Deep Bio’s prostate and frozen section algorithm into the RUO Techcyte Fusion® platform, which is CE marked in Europe and [...]

Deep Bio and Techcyte Collaborate to Bring AI Prostate and Frozen Section Solutions to Fusion® Platform2025-09-16T10:23:17+00:00

Deep Bio & Techcyte Partner to Integrate AI-Powered Prostate Diagnostics & Frozen Section on Techcyte Fusion® Platform

2025-09-05T10:57:31+00:00

Deep Bio and Techcyte expand digital pathology with AI-powered prostate and frozen section solutions on the Fusion® platform. Deep Bio, a global leader in AI-powered cancer diagnostics, today announced a strategic partnership with Techcyte to integrate Deep Bio’s prostate and frozen section algorithm into the RUO Techcyte Fusion® platform, which is CE marked in Europe and [...]

Deep Bio & Techcyte Partner to Integrate AI-Powered Prostate Diagnostics & Frozen Section on Techcyte Fusion® Platform2025-09-05T10:57:31+00:00

From Microscope to Machine Learning: 3 Digital Pathology Leaders Explore The Path to Precision Medicine

2025-09-05T10:57:24+00:00

By Nathan Buchbinder  In a recent Today’s Clinical Lab webinar, our Chief Strategy Officer Nathan Buchbinder led a discussion on insights stemming from The 2025 Laboratory Leadership Report. He was joined by three of our customers shaping the field: Dr. Derek Welch (President and Chief Medical Officer at PathGroup) Dr. Bilal Ahmad (Hematopathologist at Spectrum Healthcare [...]

From Microscope to Machine Learning: 3 Digital Pathology Leaders Explore The Path to Precision Medicine2025-09-05T10:57:24+00:00

PathAI Expands AISight® Dx Primary Diagnosis Clearance to Support VENTANA DP 200 and DP 600 Slide Scanners Through Predetermined Change Control Plan (PCCP)

2025-09-05T10:57:15+00:00

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the expansion of the AISight® Dx digital pathology image management system 510(k) label (K243391) to include the VENTANA® DP 200 and DP 600 whole slide scanners cleared in 2024 as part of the Roche Digital Pathology Dx medical device (K232879 and K242783). This expansion demonstrates PathAI’s [...]

PathAI Expands AISight® Dx Primary Diagnosis Clearance to Support VENTANA DP 200 and DP 600 Slide Scanners Through Predetermined Change Control Plan (PCCP)2025-09-05T10:57:15+00:00

Lumea Honored with Four Major Awards for Innovation and Growth in Digital Pathology

2025-09-04T12:59:25+00:00

Lumea, the U.S. leader in primary clinical digital pathology, is proud to announce it has received four prestigious awards this fall, recognizing the company's rapid growth and transformative impact on cancer diagnostics. Lumea was named to the Inc. 5000 list, the Utah Business Fast 50 list, and won both a 2025 Global Recognition Award and a [...]

Lumea Honored with Four Major Awards for Innovation and Growth in Digital Pathology2025-09-04T12:59:25+00:00

Tempus Announces the Acquisition of Paige

2025-09-02T14:48:32+00:00

Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acquisition of Paige, an AI company specializing in digital pathology. The [...]

Tempus Announces the Acquisition of Paige2025-09-02T14:48:32+00:00

Digital Pathology Tech: What Pathologists Really Want with Imogen Fitt

2025-09-02T14:48:06+00:00

Welcome to PathPulse: The Digital Diagnostic Podcast! In a world rapidly embracing digital transformation, the field of pathology is no exception. We’re on a mission to showcase the pioneers, innovators, and forward-thinkers who are not just observing but actively shaping the day-to-day use of digital pathology. In this episode, join our host, Andy Ivie—board member of [...]

Digital Pathology Tech: What Pathologists Really Want with Imogen Fitt2025-09-02T14:48:06+00:00

Mindpeak Opens Boston Office to Accelerate Precision Pathology in the US

2025-08-28T08:13:40+00:00

Local presence to help pharma, biotech, and leading laboratories match the right treatment to the right patient faster. Mindpeak, a global leader in AI-powered pathology solutions, today announced the launch of Mindpeak Inc., its dedicated US entity. Strategically positioned near key pharmaceutical, biotech, and diagnostic laboratory hubs in Boston, Massachusetts, the new presence brings Mindpeak’s [...]

Mindpeak Opens Boston Office to Accelerate Precision Pathology in the US2025-08-28T08:13:40+00:00

Emerging Biotechs, Small & Mid-Size CROs: We Now Have a Concentriq LS Package for You

2025-08-27T16:00:55+00:00

By Ritida Nanda Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire pathology for precision medicine, we’re fully empowering them with our Concentriq LS platform. Trusted by 16 of the top 20 pharmaceutical companies, [...]

Emerging Biotechs, Small & Mid-Size CROs: We Now Have a Concentriq LS Package for You2025-08-27T16:00:55+00:00

Announcing Orchard Enterprise Go-Live for P&C Labs

2025-11-26T11:17:14+00:00

Pathology and Cytology Laboratories Successfully Goes Live with Clinisys™ Orchard Enterprise Solutions and Proscia Integration. Clinisys™-Orchard Software is pleased to announce that Pathology and Cytology Laboratories (P&C Labs) completed a successful go-live of Orchard® Enterprise Lab, Orchard® Enterprise Pathology, and Orchard® Outreach, including integration to Proscia Digital Imaging system. This milestone marks a significant advancement in P&C Labs’ commitment to [...]

Announcing Orchard Enterprise Go-Live for P&C Labs2025-11-26T11:17:14+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top